HansBiomed Corporation (042520) — Cash Flow Reinvestment Rate
HansBiomed Corporation (042520) has a Cash Flow Reinvestment Rate of 0.37x as of September 2025, reinvesting ₩448.85 Million (capex ₩448.85 Million ) from operating cash flow of ₩1.21 Billion. Check HansBiomed Corporation (042520) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HansBiomed Corporation Cash Flow Reinvestment Rate (2012–2025)
Historical reinvestment intensity for HansBiomed Corporation across 10 annual periods. Explore 042520 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for HansBiomed Corporation (2012–2025)
Year-by-year capital reinvestment analysis for HansBiomed Corporation. For live market cap and broader valuation context, see HansBiomed Corporation (042520) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 5.58x | ₩1.78 Billion | ₩318.34 Million | ₩1.76 Billion | ▲ +4.2% |
| 2024 | 5.36x | ₩9.42 Billion | ₩1.76 Billion | ₩2.83 Billion | ▲ +127.0% |
| 2020 | 2.36x | ₩13.57 Billion | ₩5.75 Billion | ₩7.05 Billion | ▼ -19.2% |
| 2019 | 2.92x | ₩22.54 Billion | ₩7.71 Billion | ₩15.56 Billion | ▲ +282.6% |
| 2018 | 0.76x | ₩3.97 Billion | ₩5.20 Billion | ₩2.24 Billion | ▼ -67.7% |
| 2017 | 2.37x | ₩13.24 Billion | ₩5.60 Billion | ₩13.05 Billion | ▲ +30.9% |
| 2015 | 1.81x | ₩6.26 Billion | ₩3.47 Billion | ₩6.07 Billion | ▼ -72.1% |
| 2014 | 6.47x | ₩13.35 Billion | ₩2.06 Billion | ₩12.39 Billion | ▲ +107.1% |
| 2013 | 3.13x | ₩7.29 Billion | ₩2.33 Billion | ₩7.29 Billion | ▲ +1750.5% |
| 2012 | 0.17x | ₩253.56 Million | ₩1.50 Billion | ₩253.56 Million | — |